Improving HIV prevention for African American women in the South
Optimizing PrEP uptake for African American women in the South by empowering women to make informed HIV prevention and sexual health choices
This study is all about helping African American women in the Southern U.S. learn more about PrEP, a medication that can prevent HIV, by providing support and resources to overcome challenges they face, so they can make informed choices about their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-10991544 on NIH RePORTER |
What this research studies
This research focuses on increasing the use of pre-exposure prophylaxis (PrEP) among African American women in the Southern United States, who are disproportionately affected by HIV. The project aims to empower these women by providing education about PrEP, addressing barriers such as stigma and discrimination, and enhancing access to healthcare resources. By fostering informed decision-making and resilience, the research seeks to improve both the uptake and persistence of PrEP use among eligible women. The approach is holistic, considering the social and systemic factors that impact women's health choices.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American women living in the Southern United States who are at risk for HIV.
Not a fit: Patients who are not at risk for HIV or who do not identify as African American women may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the rates of HIV infections among African American women in the South.
How similar studies have performed: Previous research has shown success in similar approaches aimed at increasing PrEP uptake among marginalized populations, indicating potential for positive outcomes in this study.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Haider, Mohammad Rifat — University of Georgia
- Study coordinator: Haider, Mohammad Rifat
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.